Nasdaq
MDGL
Madrigal Pharmaceuticals, Inc.
- Health Care
- Listed 2007
- 1 day
- −0.7%
- 1 month
- −6.4%
- 1 year
- +50.9%
$510.36 · Mkt cap $11.8B
At the 6 Aug 2026 close
Nasdaq
Madrigal Pharmaceuticals, Inc.
$510.36 · Mkt cap $11.8B
At the 6 Aug 2026 close
Madrigal Pharmaceuticals, Inc. trades under the ticker MDGL on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2007. Its market capitalisation is $11.8B. The last closing price was $510.36, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +50.9%, and −6.4% over the past month. Returns are price returns and exclude dividends.
This page exists because MDGL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.